agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $1.92 billion. The enterprise value is $1.71 billion.
| Market Cap | 1.92B |
| Enterprise Value | 1.71B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 16.80 million shares outstanding. The number of shares has increased by 0.83% in one year.
| Current Share Class | 16.79M |
| Shares Outstanding | 16.80M |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | +2.76% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 64.77% |
| Float | 10.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 47.67 |
| PS Ratio | 0.31 |
| Forward PS | 0.30 |
| PB Ratio | 5.75 |
| P/TBV Ratio | 8.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.13 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.48 |
Financial Efficiency
Return on equity (ROE) is -36.15% and return on invested capital (ROIC) is -18.93%.
| Return on Equity (ROE) | -36.15% |
| Return on Assets (ROA) | -3.94% |
| Return on Invested Capital (ROIC) | -18.93% |
| Return on Capital Employed (ROCE) | -29.98% |
| Weighted Average Cost of Capital (WACC) | 21.25% |
| Revenue Per Employee | $7.01M |
| Profits Per Employee | -$101,750 |
| Employee Count | 856 |
| Asset Turnover | 3.80 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $4.98 million in taxes.
| Income Tax | 4.98M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +530.10% in the last 52 weeks. The beta is 3.11, so agilon health's price volatility has been higher than the market average.
| Beta (5Y) | 3.11 |
| 52-Week Price Change | +530.10% |
| 50-Day Moving Average | 87.91 |
| 200-Day Moving Average | 66.42 |
| Relative Strength Index (RSI) | 77.43 |
| Average Volume (20 Days) | 211,139 |
Short Selling Information
The latest short interest is 899,148, so 5.35% of the outstanding shares have been sold short.
| Short Interest | 899,148 |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 5.35% |
| Short % of Float | 8.23% |
| Short Ratio (days to cover) | 3.93 |
Income Statement
In the last 12 months, agilon health had revenue of $6.00 billion and -$87.10 million in losses. Loss per share was -$5.23.
| Revenue | 6.00B |
| Gross Profit | 179.47M |
| Operating Income | -99.59M |
| Pretax Income | -101.12M |
| Net Income | -87.10M |
| EBITDA | -85.93M |
| EBIT | -99.59M |
| Loss Per Share | -$5.23 |
Balance Sheet
The company has $239.76 million in cash and $33.43 million in debt, with a net cash position of $206.34 million or $12.28 per share.
| Cash & Cash Equivalents | 239.76M |
| Total Debt | 33.43M |
| Net Cash | 206.34M |
| Net Cash Per Share | $12.28 |
| Equity (Book Value) | 280.88M |
| Book Value Per Share | 16.72 |
| Working Capital | 166.47M |
Cash Flow
In the last 12 months, operating cash flow was -$4.23 million and capital expenditures -$12.77 million, giving a free cash flow of -$17.01 million.
| Operating Cash Flow | -4.23M |
| Capital Expenditures | -12.77M |
| Depreciation & Amortization | 13.66M |
| Net Borrowing | -3.50M |
| Free Cash Flow | -17.01M |
| FCF Per Share | -$1.01 |
Margins
Gross margin is 2.99%, with operating and profit margins of -1.66% and -1.45%.
| Gross Margin | 2.99% |
| Operating Margin | -1.66% |
| Pretax Margin | -1.68% |
| Profit Margin | -1.45% |
| EBITDA Margin | -1.43% |
| EBIT Margin | -1.66% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.83% |
| Earnings Yield | -4.58% |
| FCF Yield | -0.92% |
Analyst Forecast
The average price target for agilon health is $115.83, which is 1.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $115.83 |
| Price Target Difference | 1.53% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 5.43% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
agilon health has an Altman Z-Score of 2.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.46 |
| Piotroski F-Score | 4 |